You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Lymphoma, T-Cell

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

T-Cell Lymphoma Trial (Brentuximab vedotin)

Not yet recruiting
  • T-Cell Lymphoma
  • Brentuximab vedotin
  • (no location specified)
Jun 30, 2022

NK/T-cell Lymphoma Trial in Shanghai (Positron Emission Tomography/Magnetic Resonance (PET/MR))

Not yet recruiting
  • NK/T-cell Lymphoma
  • Positron Emission Tomography/Magnetic Resonance (PET/MR)
  • Shanghai, Shanghai, China
    Ruijin Hospital
Dec 14, 2022

Peripheral T Cell Lymphoma Trial (CHOP+selinexor+5-Azacitidine, CHOP+duvelisib+5-Azacitidine, CHOP+chidamide+tislelizumab)

Not yet recruiting
  • Peripheral T Cell Lymphoma
  • (no location specified)
Dec 29, 2022

Extranodal NK/T-cell Lymphoma Trial (Sugemalimab, Placebo, Pegaspargase)

Not yet recruiting
  • Extranodal NK/T-cell Lymphoma
  • Sugemalimab
  • +4 more
  • (no location specified)
Jan 17, 2023

Peripheral T-Cell Lymphoma With Follicular Helper of T Cell Phenotype Trial in Guangzhou (Chidamide combined with CHOP,

Recruiting
  • Peripheral T-Cell Lymphoma With Follicular Helper of T Cell Phenotype
  • Guangzhou, Guangdong, China
    Sun Yat-sen Universitiy Cancer Center, Sun Yat-Sen University
Oct 7, 2022

T-Cell Lymphoma Trial (Brentuximab vedotin, Pembrolizumab)

Not yet recruiting
  • T-Cell Lymphoma
  • (no location specified)
Jul 22, 2022

NK/T Cell Lymphoma, Vascular Immunomother T Cell Lymphoma, Non-Hodgkin Lymphoma Trial in Guangzhou (GNC-038)

Not yet recruiting
  • NK/T Cell Lymphoma
  • +2 more
  • Guangzhou, Guangdong, China
  • +1 more
Jan 12, 2023

T Lymphoblastic Leukemia/Lymphoma Trial in Shenzhen (CD7 CAR-T cells)

Recruiting
  • T Lymphoblastic Leukemia/Lymphoma
  • CD7 CAR-T cells
  • Shenzhen, Guangdong, China
    Li Yu
Nov 11, 2022

Peripheral T Cell Lymphoma Trial in Shanghai (Azacitidine Injection, Dasatinib, Linperlisib)

Recruiting
  • Peripheral T Cell Lymphoma
  • Azacitidine Injection
  • +6 more
  • Shanghai, Shanghai, China
    Ruijin Hospital, Shanghai Jiao Tong University School of Medicin
Nov 8, 2022

Peripheral T-cell Lymphoma Trial in Tianjin (Lposomal mitoxantrone HCl,Cyclophosphamide,Vincristine,Etoposide and

Not yet recruiting
  • Peripheral T-cell Lymphoma
  • Lposomal mitoxantrone hydrochloride,Cyclophosphamide,Vincristine,Etoposide and Prednisone(CMOEP)
  • Tianjin, Tianjin, China
    Tianjin Medical University Cancer Insititute & Hospital
Jul 13, 2022

T Cell Lymphoma Trial (Cidapenem combined with azacitidine and mitoxantrone liposome (CAM) regimen)

Not yet recruiting
  • T Cell Lymphoma
  • Cidapenem combined with azacitidine and mitoxantrone liposome (CAM) regimen
  • (no location specified)
Mar 6, 2023

Tissue Repository: CTCL Collection Protocol

Recruiting
  • Lymphoma, T-Cell, Cutaneous
  • +2 more
    • New York, New York
      Columbia University Medical Center
    May 2, 2022

    Cutaneous T-Cell Lymphoma/Mycosis Fungoides Trial in Fairport (Hypericin)

    Active, not recruiting
    • Cutaneous T-Cell Lymphoma/Mycosis Fungoides
    • Fairport, New York
      Rochester Skin Lymphoma Medical Group
    Jun 28, 2022

    Lymphoma Trial (Tislelizumab)

    Not yet recruiting
    • Lymphoma
    • (no location specified)
    Jul 28, 2022

    Cutaneous T Cell Lymphoma Trial in Chicago (APR-TD011 (RLF-TD011))

    Not yet recruiting
    • Cutaneous T Cell Lymphoma
    • APR-TD011 (RLF-TD011)
    • Chicago, Illinois
      Dermatology CTU
    Feb 6, 2023

    Adult T-cell Leukemia/Lymphoma, Extranodal NK-/T-cell Lymphoma, Nasal Type, Enteropathy-Associated T-Cell Lymphoma Trial run by

    Not yet recruiting
    • Adult T-cell Leukemia/Lymphoma
    • +4 more
    • CC-486 (5-azacitidine)
    • +3 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Aug 17, 2022

    NK-T-Cell Lymphoma, Extranodal Trial (Pegaspargase Combined With Gemcitabine, Etoposide, Liposomal Mitoxantrone Hydrochloride

    Not yet recruiting
    • NK-T-Cell Lymphoma, Extranodal
    • Pegaspargase Combined With Gemcitabine, Etoposide, Liposomal Mitoxantrone Hydrochloride and Dexamethasone (P-GEMD) regimen
    • (no location specified)
    Mar 7, 2023

    T-cell Lymphoma, Virus, Intravenous Injection Trial (Oncolytic Virus Injection(RT-01))

    Not yet recruiting
    • T-cell Lymphoma
    • +2 more
    • Oncolytic Virus Injection(RT-01)
    • (no location specified)
    May 18, 2022

    T-Cell Lymphoma, Peripheral T-Cell Lymphoma Refractory, Cutaneous T-Cell Lymphoma Refractory Trial in United States (LB1901)

    Active, not recruiting
    • T-Cell Lymphoma
    • +4 more
    • LB1901
    • Rochester, Minnesota
    • +3 more
    Feb 15, 2022

    Peripheral T Cell Lymphoma Trial in Zhejiang (Mitoxantrone liposome?Chidamide?Azacitidine)

    Recruiting
    • Peripheral T Cell Lymphoma
    • Mitoxantrone liposome、Chidamide、Azacitidine
    • Zhejiang, Zhejiang, China
      Second Affiliated Hospital, School of Medicine, Zhejiang Univers
    Aug 9, 2022

    T Lymphoblastic Leukemia/Lymphoma, T-cell Acute Lymphoblastic Leukemia, Peripheral T Cell Lymphoma Trial in Shanghai (anti-CD7

    Recruiting
    • T Lymphoblastic Leukemia/Lymphoma
    • +4 more
    • anti-CD7 CAR-T cells
    • Shanghai, China
      Xianmin General Song
    May 3, 2022

    Lymphoma, T-Cell Trial in Yanda (Senl-T7)

    Recruiting
    • Lymphoma, T-Cell
    • Senl-T7
    • Yanda, Hebei, China
      Hebei yanda Ludaopei Hospital
    May 24, 2022

    T Cell Lymphoma Trial in Seoul (ACHOP)

    Not yet recruiting
    • T Cell Lymphoma
    • Seoul, Korea, Republic of
      81, Irwon-ro, Gangnam-gu, Seoul, Republic of Korea
    Apr 18, 2022

    T-cell Non-Hodgkin's Lymphoma Trial (CD147- CAR T cells)

    Not yet recruiting
    • T-cell Non-Hodgkin's Lymphoma
    • CD147- CAR T cells
    • (no location specified)
    Aug 1, 2022

    Peripheral T-cell Lymphoma Targeted Therapy Trial in Tianjin (Azacitidine, Chidamide, Cyclophosphamide)

    Enrolling by invitation
    • Peripheral T-cell Lymphoma Targeted Therapy
    • Tianjin, Tianjin, China
      Tianjin Medical University Cancer Insititute & Hospital
    Jan 9, 2023